(Q51750562)
Statements
Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization. (English)
1 reference
Timothy J Kinsella
1 reference
Michael T Kinsella
1 reference
Seongwon Hong
1 reference
Jerry P Johnson
1 reference
Brian Burback
1 reference
Patricia J Tosca
1 reference
12 June 2007
1 reference
61
1 reference
2
1 reference
323-334
1 reference